May 11th- Beyond the webinar: ISKIA and the New Era of MRD-Driven Myeloma Therapy: Are We Moving Closer to Cure?

May 18th- Can Peripheral Blood Replace Bone Marrow for MRD Monitoring in Myeloma?

May 8th- Beyond the webinar: Multiple Myeloma in 2026: Innovation Meets Reality – Lessons from the Australian Experience

May 7th- Beyond the webinar: Busulfan in Hematology – From Empiricism to Precision Conditioning

May 4th- Reinventing Drug Delivery in Multiple Myeloma: The Rise of the On-Body Injector for Isatuximab

May 1st- Beyond the Webinar: CAR-T Cells- From Breakthrough to Global Transformation

May 5th- Dr. Neta Nevo- Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel

April 27th- Prof. Robert Zeiser- Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML

April 22nd- Hepta-Refractory Myeloma: When Targets Disappear

April 20th- Beyond the webinar: Non-Transfusion-Dependent Thalassemia: From Observation to Intervention